Nonrelated Party was Regen BioPharma’s largest revenue line in fiscal 2025, bringing in $126.56K of $236.56K (53%).
| Related Party Transactions By Related Party | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Nonrelated Party | $126.56K | $126.56K | $126.56K |
| Related Party | $110.00K | $110.00K | $110.00K |
| Total | $236.56K | $236.56K | $236.56K |
Regen BioPharma brought in $236.56K from its two revenue lines in fiscal 2025, the year ended September 30, 2025. That was up 0.0% from $236.56K in fiscal 2024. Nonrelated Party was the largest at $126.56K (53.5%), ahead of Related Party at $110.00K (46.5%).
Compared with fiscal 2024, Related Party grew 0.0% to $110.00K and Nonrelated Party grew 0.0% to $126.56K. From fiscal 2023 to 2025, combined revenue from these revenue lines grew from $236.56K to $236.56K, a compound annual growth rate of 0.0%. Nonrelated Party's share held steady at about 53.5%.
Regen BioPharma (RGBP) reports its revenue by related party transactions by related party. In fiscal 2025, Nonrelated Party was its largest revenue line, bringing in $126.56K (53.5% of the total), followed by Related Party at $110.00K (46.5%).
Nonrelated Party was Regen BioPharma's largest revenue line in fiscal 2025, bringing in $126.56K, or 53.5% of the $236.56K total across its two revenue lines.
Related Party grew faster than Nonrelated Party in fiscal 2025, up 0.0% from $110.00K to $110.00K. Nonrelated Party grew 0.0% to $126.56K.
Every figure comes from Regen BioPharma's annual financial filings, as reported. Each line keeps the name Regen BioPharma gives it, and years follow its fiscal calendar.
Regen BioPharma's revenue by related party transactions by related party goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.